Publications by authors named "A Villasenor"

Rationale: Biologics are becoming increasingly important in the management of severe asthma. However, little is known about the systemic immunometabolic consequences of Th2 response blockage.

Objectives: To provide a better immunometabolic understanding of the effects of mepolizumab and omalizumab treatments by identifying potential biomarkers for monitoring.

View Article and Find Full Text PDF

Macrophages in the B cell lymphoma microenvironment represent a functional node in progression and therapeutic response. We assessed metabolic regulation of macrophages in the context of therapeutic antibody-mediated phagocytosis. Pentose phosphate pathway (PPP) inhibition induces increased phagocytic lymphoma cell clearance by macrophages in vitro, in primary human chronic lymphocytic leukemia (CLL) patient co-cultures, and in mouse models.

View Article and Find Full Text PDF

Persistent and unresolved inflammation is a common underlying factor observed in several and seemingly unrelated human diseases, including cardiovascular and neurodegenerative diseases. Particularly, in atopic conditions, acute inflammatory responses such as those triggered by insect venom, food or drug allergies possess also a life-threatening potential. However, respiratory allergies predominantly exhibit late immune responses associated with chronic inflammation, that can eventually progress into a severe phenotype displaying similar features as those observed in other chronic inflammatory diseases, as is the case of uncontrolled severe asthma.

View Article and Find Full Text PDF

Background: The pathological mechanism of the gastrointestinal forms of food allergies is less understood in comparison to other clinical phenotypes, such as asthma and anaphylaxis Importantly, high-IgE levels are a poor prognostic factor in gastrointestinal allergies.

Methods: This study investigated how high-IgE levels influence the development of intestinal inflammation and the metabolome in allergic enteritis (AE), using IgE knock-in (IgEki) mice expressing high levels of IgE. In addition, correlation of the altered metabolome with gut microbiome was analysed.

View Article and Find Full Text PDF
Article Synopsis
  • Allergic diseases, starting early in life, create a chronic inflammatory environment that is linked to metabolic disorders and cardiovascular risks, but the exact mechanisms are still unclear.
  • Researchers conducted experiments using a mouse model and various methods to study how allergic inflammation impacts lipid metabolism, specifically focusing on triglyceride levels and gene expression related to fat metabolism.
  • The findings indicate that allergic inflammation leads to a specific lipid profile and increased triglycerides in the blood, primarily driven by IgG-mediated responses rather than traditional T-cell reactions.
View Article and Find Full Text PDF